hims semaglutide out of stock & Hers Pops on a Deal With Rival Novo Nordisk—What You Need to Know Hims expansion may not come

Editors note: This article was updated on April 23, 2025, to include a statement from Empower Pharmacy.

Clinical trial data from the STEP programme suggests that patients lose an average of 5% to 8% of their starting body weight over the first three months

This targeted delivery concentrates the peptides regenerative effects exactly where they are needed most

This suggests that semaglutide maintains metabolic activity (or prevents compensatory downregulation of EE) despite weight loss, thereby aiding in prolonged weight loss or maintenance

Related: What is IBS, and what can you do to ease the symptoms

2022;2022:e9615674